Price targets, page-40

The pattern with the market is it always overbuys on good news and then always oversells after it. Bulls and bears are just greed and fear in a boxing ring. Many people are day-traders and the quick ones ones got in early at about $33 and sold above $40 but have dumped. Then there are the hopefuls who bought in way too high ($40+) hoping it would now be $60+. The selling off is the post-hype hangover. The run started at about $28 on the day the FDA announcement came out, so sadly, it may settle that low again because you need to remember - it's only a rubber stamp. The product still needs to be made and hit the shelves, and the cash has to hit the bank. Until that happens, CUV is just a pretty girl in a glossy magazine - she's nice to look at, but you can't hold her hand.
One needs faith at this time - the story is still evolving. Remember the market is simply impatient investors handing over their money to patient investors.
How many CUV's made it this far, and how many have dismally failed? This stock is only one of 15 that I traded in 20 years ago - the rest are all gone. This glass is still very much half-full.